» Advanced search
Only first 10,000 results will be saved in the file.
No item is selected. Use checkboxes to select search results.
Displaying 926-950 of 1083 results.
 
{{ selectedCountPage }} items selected on this page, {{ selectedCountPage }} item selected on this page, {{ selectedCountTotal }} item in total {{ selectedCountTotal }} items in total
: Abnormal lab. findings Secondary outcomes: Occurrence of COVID-19 disease 2 weeks after 2nd vaccine dose (...) Study aim: Dose finding, safety and immunogenicity of recombinant protein sub-unit Covid vaccine (...) ; healthy based on clinical & laboratory criteria; Negative RT-PCR tests for COVID, Negative S antibody
IRCTID: IRCT20201214049709N1
  1. Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial
  2. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy children and adolescents aged 5-17 years; single group, open label study
  3. Immunogenicity and Safety of intranasal Razi Cov Pars as a booster dose in adult population; randomised, double blind, placebo controlled clinical trial
  4. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  5. Comparison of the safety and efficacy of Razi SARS-CoV-2 recombinant Spike protein (Razi Cov Pars) and Sinopharm vaccines in adults aged 18 and over, a phase III randomised, double blind, non-inferiority clinical trial
  6. Comparison of immunogenicity and safety of Razi Cov Pars and Sinopharm booster doses in adults 18 years of age and older who have primarily vaccinated with Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial ‎
  7. A double-blind, randomized, placebo-controlled Phase II clinical trial to evaluate the immunogenicity and safety of covid-19 recombinant RBD protein vaccine (80 microgram) of Plasma Darman Sarve Sepid Co. in healthy population.
  8. Comparison of safety and immunogenicity of FAKHRAVAC and Sinopharm booster doses for adults 18 years of age and older, fully vaccinated by Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial
  9. Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial
  10. A randomized, double-blinded, placebo-controlled phase I clinical trial to evaluate the safety and immunogenicity of three dose regimens of COVID-19 RBD protein recombinant vaccine (AmitisGen; 80µg and 120µg) in a healthy population
Study aim: Investigation the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with COVID-19 pneumonia- A Phase 2&3 Clinical Trial Design: Clinical trial (...) : Patients aged between 18-95 years Patients Approved for Covirus 19 by Laboratory Methods Patients with mild
IRCTID: IRCT20140911019125N8
  1. Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with COVID-19 pneumonia
  2. Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with Idiopathic pulmonary Fibrosis- A Phase 1&2 Clinical Trial
  3. Evaluation of the efficacy and safety of cord-derived mesenchymal stem cell transplantation in the treatment of COVID-19
  4. Human Placenta-Derived Mesenchymal Stem Cell Transplantation in Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19: Phase I Clinical Trial)
  5. Clinical trial of efficacy and safety of mesenchymal stem cell transplantation in patients with COVID-19 pneumonia
  6. Evaluation of the therapeutic effect of nebulized addipose tissue- derived mesenchymal stem cells conditioned media on covid -19 pneumonia
  7. Investigation of the effects of the exosomes derived from placental mesenchymal stem cells on the oxygen saturation and biological markers of patients with COVID-19
  8. Safety and efficacy study of allogeneic human menstrual blood stem cells secretome to treat severe Covid-19 patients, clinical trial phase I&II
  9. Study of the effect of intravenous injection of Deciduous dental pulp mesenchymal stem cell in hematopoietic stem cell engraftment after autologus hematopoietic stem cell transplantation (HSCT) in patients with Hodgkin and non-Hodgkin Lymphoma
  10. A comparison of two stem cells utilization methods; intravenous and intra alveolar injection by bronchoscopy on outcome of severe lung contusion in patients admitted to intensive care unit (ICU)
Study aim: Evaluation of the efficacy of Gallecina® oral capsules, a hydrogen sulfide prodrug, as an adjuvant therapy in hospitalized patients with COVID-19 Design: a randomized placebo-controlled triple-blind phase 3 clinical trial on 148 patients with COVID-19 Settings and conduct: In the drug and
IRCTID: IRCT20201111049347N1
Study aim: Evaluation of the effectiveness of integrated drug therapy and respiratory training with incentive spirometer on mortality and recovery rates of adult patients admitted to hospital with Covid 19 (...) . Settings and conduct: Participants are among 19 patients admitted to the non-intensive care unit of Imam
IRCTID: IRCT20201012049010N2
Criteria: -Patients aged between 18-95 years - Patients Approved for Covirus 19 by Laboratory Methods
IRCTID: IRCT20140911019125N6
  1. Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with COVID-19 pneumonia- A Phase 2&3 Clinical Trial
  2. Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with Idiopathic pulmonary Fibrosis- A Phase 1&2 Clinical Trial
  3. Study the effect of intravenous injection of dental pulp mesenchymal stem cells in treatment of patients with Limb-Girdle Muscular Dystrophy (LGMD)- A Phase 1 & 2 Clinical Trial
  4. Cell therapy in patients with COVID-19 using mesenchymal stem cells: Phase 2 clinical trial
  5. Evaluation of the efficacy and safety of cord-derived mesenchymal stem cell transplantation in the treatment of COVID-19
  6. Study of the effect of intravenous injection of Deciduous dental pulp mesenchymal stem cell in hematopoietic stem cell engraftment after autologus hematopoietic stem cell transplantation (HSCT) in patients with Hodgkin and non-Hodgkin Lymphoma
  7. Human Placenta-Derived Mesenchymal Stem Cell Transplantation in Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19: Phase I Clinical Trial)
  8. Study the therapeutic effect of cellular fibrin membrane with dental pulp mesenchymal stem cells in treatment of ocular chemical injuries in human- A phase 1&2 clinical trial
  9. Clinical trial study of safety and efficacy assessment of human umbilical cord matrix mesenchymal stem cell infusion on the treatment of new coronavirus 2019 pneumonia in humans
  10. Investigating the effect of intravenous injection of deciduous tooth pulp mesenchymal stem cells in patients with uncompensated liver cirrhosis in order to reduce the complications of the disease
and exclusion criteria: Inclusion criteria: Age more than 18 years; Not having COVID 19 since the
IRCTID: IRCT20210206050259N4
  1. Comparison of immunogenicity and safety of Razi Cov Pars and Sinopharm booster doses in adults 18 years of age and older who have primarily vaccinated with Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial ‎
  2. Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial
  3. Immunogenicity and safety of pastocovac vaccine as a booster dose in comparison with sinopharm and pastocovac Plus boosters in Iranian adults aged 18 to 80 who received 2 doses of Sinopharm vaccine: a parallel group clinical trial
  4. Phase I, Safety and Immunogenicity of Razi SARS-CoV-2 recombinant Spike protein vaccine (Razi Cov Pars), in healthy adults aged 18-55 years; parallel 4 arms design (adjuvant only and three vaccine doses of 5, 10, and 20 µg/200µl); a Randomised, double blind, clinical trial
  5. Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial
  6. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy children and adolescents aged 5-17 years; single group, open label study
  7. Phase 1, safety, immunogenicity and dose finding for two strengths of 0.5 × 10^6 and 2.5 × 10^6 (TCID50) inactivated SARS-CoV-2 vaccine FAKHRAVAC (MIVAC) injected in two schedules of two doses, 2 and 3 weeks apart in healthy adults aged 18-55 years: a randomized, double blind, placebo controlled, clinical trial
  8. Immunogenicity and Safety of intranasal Razi Cov Pars as a booster dose in adult population; randomised, double blind, placebo controlled clinical trial
  9. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  10. Immunogenicity and safety evaluation of Pastocovac Plus as the booster dose in Iranian adults aged from 18 to 80 who received two doses of Sinopharm and Astrazeneca
minutes. Main outcome variables: Anxiety related to COVID, Accuracy, Job Stress.
IRCTID: IRCT20140428017468N6
  1. Investigating the effect of aromatherapy with Rosa damascena mill L. oil on severity of fatigue and physical discomfort of operating room nurses at Qom university of Medical Sciences hospitals
  2. The effect of aromatherapy with sour lemon essential oil on the level of occupational stress and occupational fatigue among operating room technologists
  3. Rosa Damascena effect on pain and anxiety in first stage of labor in nulliparous women
  4. The effect of aromatherapy with lavender oil on post dura puncture headache
  5. The effect of inhaled Rosa damascena (Damask Rose) aromatherapy on the severity of anxiety in adults following lower extremity orthopedic surgery
  6. Evaluation effects of aromatherapy with Rosa Damascena on anxiety of mothers with premature infants admitted to the neonatal intensive care unit (NICU)
  7. Comparison of the effect of aromatherapy with essence of Rosa Damascena and Bitter Orange (Citrus aurantium ) Blossom on symptoms of premenstrual syndrome in students of Shiraz University, 2015
  8. Comparison of the effect of aromatherapy with rosa damascena, lavender and citrus aurantium essential oils on the severity of premenstrual syndrome symptoms in married women
  9. Comparison of the effect of concomitant exercise and Aromatherapy on the Fatigue severity of Surgical Technologists.
  10. The effect of inhalation aromatherapy with Damask Rose ( Rose Damascena) essential oil versus placebo on the pain and vital signs in the burn patients after dressing: a single blinded randomized clinical trial
Study aim: Determining the Effect of Teaching Resilience Techniques by Microlearning Method on Stress, Anxiety and Happiness of Nurses in Special Care Units During the COVID-19 Pandemic in Selected (...) , ICU with patients with covid-19 3. Have at least a Bachelor's degree in nursing 4. Access to
IRCTID: IRCT20221225056916N1
  1. Designing a hospital triage training application based on the microlearning method and comparing its effect with the lecture method on the Learning outcomes of nursing students of Aja University of Medical Sciences..
  2. Investigation of microlearning-based education effect on medication adherence and health literacy in elderly population with multimorbidity of Baqiyatallah University Retirement Center
  3. The Effectiveness of Resilience Training Program on Job Burnout of Nurses in Special Units
  4. Effect of happiness educational program on the level of nurses’ happiness , stress , anxiety , and depression
  5. A comparative Study on the effect of anxiety management training on two methods of Microlearning and a Gamification based website on anxiety control in 13-15 years old adolescent girls in Shiraz
  6. Investigating end of life advance care planning with a microlearning method on the readiness and self-efficacy decision making in the family care givers of patient with advanced cancer
  7. The effect of Jacobsen relaxation application on anxiety and job stress of nurses caring for Covid 19 patients
  8. The effect of time management training on stress and resilience of novice nurses working in Covid 19 wards in educational hospitals of Mashhad University of Medical Sciences
  9. Investigating the Impact of the work environment stress management program on the resilience of emergency department nurses
  10. To assess the efficacy of teaching and training techniques to improve the resilience of nurses in the COVID-19 pandemic
Study aim: The aim of this study was to investigate the effect of foot reflexology on the level of anxiety, shortness of breath and fatigue in patients with coronavirus. Design: The clinical trial has a control group, two-way blind, randomly, simple random method on 40 patients with COVID 19. Settings and
IRCTID: IRCT20220405054421N1
and breastfeeding, symptomatic COVID infection, fever on arrival or within 3 days before the visit (...) reaction to any type of vaccine. (anaphylactic shock), injection of COVID vaccine at least 2 weeks before
IRCTID: IRCT20210901052358N5
  1. Safety evaluation of a quadrivalent recombinant influenza vaccine (serotypes of 2021/2022) manufactured by Nivad Pharmed Salamat, open label, single arm, in volunteers aged ≥ 18 years.
  2. Immunogenicity and safety evaluation of FluGuard® (quadrivalent recombinant influenza vaccine manufactured by Nivad Pharmed Salamat), in comparison with Vaxigrip Tetra (quadrivalent inactivated influenza vaccine manufactured by Sanofi Pasteur) in a double-blind, active-controlled, parallel, non-inferiority clinical trial in healthy voluntaries aged 9 to 18 years
  3. Immunogenicity and safety evaluation of FluGuard® (seasonal quadrivalent recombinant influenza vaccine manufactured by Nivad Pharmed Salamat), in comparison with Vaxigrip Tetra (quadrivalent inactivated influenza vaccine manufactured by Sanofi Pasteur)
  4. Evaluation of the immunogenicity and safety of quadrivalent flu vaccine (Fluguard) manufactured by Nivad pharmed Salamat, in comparison with seasonal flu vaccine Vaxigrip, as a reference product made by Sanofi, France in healthy volunteers aged 18 to 49 years, study Clinical phase 3 random, double-blind, double-arm, parallel, active control, non-inferiority
  5. Clinical trial of the immunogenicity and safety of Papilloguard 4 vaccine (quadrivalent manufactured by Nivad Pharmed Salamat company) compared to Gardasil vaccine (quadrivalent, reference product, Merck company) by comparing the ratio of GMT (Geometric Mean Titer) in healthy male and female volunteers 15 to 25 years: a phase 3 randomized, parallel, double-blind, noninferiority clinical trial
  6. Clinical study of immunogenicity and safety of human papilloma virus vaccine (quadrivalent, reference product, produced by Biosun pharmed Co.) compared to Gardasil vaccine (quadrivalent, produced by Merck Co.) in healthy adults aged 15-35 years: A phase 3, randomized, double-blinded, parallel, active-controlled, non-inferiority clinical trial
  7. Studying the efficiency of inactivated split-virion Influenza vaccine (Flupak) in healthy adult volunteers in comparison with Vaxigrip Influenza vaccine: ‎Phase 2 clinical trial (safety, adverse events and immunogenicity)‎
  8. Comparison of safety and efficacy of standard dose and doubling of seasonal flu vaccine in patients receiving kidney transplantation in Imam Khomeini Hospital, 2021
  9. Evaluation of zinc effect on antibody titers of seasonal infiuenza vaccination in hemodialysis person.
  10. The phase 3, randomized, two-arm, parallel group, double-blind, active controlled non-inferiority clinical trial evaluating the immunogenicity and safety of the 13-valent pneumococcal vaccine (PneumoConj®- manufactured by Nivad Pharmed Salamat), compared to the 13-valent pneumococcal vaccine (Prevnar®- manufactured by Pfizer) as the reference product, in infants aged 8 ± 2 weeks
study Inclusion criteria: Age 18 to 65 years Diagnosis of Qovid 19 infection based on the approval of a
IRCTID: IRCT20211112053046N1
20 beats per minute. 7. At the time of conducting the study, they should not be infected with Covid-19 or during the recovery period. 8. Not participating in regular and professional sports activities
IRCTID: IRCT20220131053897N1
  1. The effect of Basic Cardiopulmonary and Cerebral Resuscitation (CPCR) education by peer learning on skill and knowledge of emergency medical ambulance workers Kohgiloye and Bovirahmad province in year 1392.
  2. Compare the effect of the musical-verbal CPR code announcement with the verbal (code 99) CPR code announcement on the time of the presence of the CPR team members at the patients' bedside in the motehari hospital.l
  3. Effectiveness of an Interactive Nursing Application on Nurses` Knowledge toward Pediatric Cardiopulmonary Resuscitation
  4. The effect of personalized video feedback of Basic Life Support on knowledge، performance and Satisfaction of nursing undergraduate students
  5. Investigating the effect of the educational intervention based on the health belief model (HBM) in improving the time of using personal protective equipment
  6. Investigating the effect of training based on the escape room game on team management of cardiopulmonary resuscitation in nursing students
  7. Effect of Hearing Simulated Intrauterine Sound on the Behavioral and Physiological Indicators of pain due to Blood Sampling in Preterm Infants
  8. Comparison of simulation training based on mannequins method with virtual method on the learning rate of cardiopulmonary resuscitation of nursing students
  9. Comparison effect of cardiopulmonary resuscitation education with serious game on the base of smart phone and simulation methods on knowledge, attitude and performance of nursing students
  10. Evaluating performance of facemasks in reducing ambient particulate matter (PM10، PM2.5، PM1) exposure and theirs wearing on acute cardiovascular effects: A Randomized crossover trial
Study aim: Determining the impact of using the most appropriate existing mobile health App, and an innovative mobile health App in a nutritional intervention study in pregnancy Design: A phase 2 clinical trial study without blinding and with parallel design will be performed on 60 pregnant mothers with a gestational age of less than 20 weeks. Participants will be randomly assigned to study groups using the table of random numbers. Settings and conduct: Study site: Health care centers of 3 medical universities in Tehran province Method: The intervention will start from the 20th week of pregnancy. In addition to routine pregnancy care, intervention groups will receive the most appropriate available or an innovative mobile health app in the field of nutritional intervention, along with training on how to use the app. Routine prenatal care will be provided until delivery, and data including blood pressure, weight, and pregnancy complications will be recorded. The use of the application will also be assessed. Participants/Inclusion and exclusion criteria: Pregnant mothers with: singleton pregnancy, over 18 years of age, gestational age under 20 weeks, having a smart phone; and without: chronic systemic diseases, eating disorders, any medication use, and movement disorders Intervention groups: - The 1st intervention group: Using the most appropriate mobile health application available in the field of nutritional intervention - The 2nd intervention group: Using an innovative mobile health application produced in the field of nutritional intervention by researchers - Control group: Only routine pregnancy care Main outcome variables: Weight gain during pregnancy, weight, height, and head circumference of the newborn at birth
IRCTID: IRCT20211229053562N1
Study aim: Determining the efficacy of Tofacitinib/Remdesivir combination therapy compared to Remdesivir treatment on clinical status and laboratory findings of patients with severe Covid-19 Design: A clinical trial with a control group, with parallel groups, double-blind, randomized block, phase 2-3 on 48
IRCTID: IRCT20200426047212N2
  1. Effectiveness evaluation of Tofacitinib plus Remdesivir in comparison with Remdesivir in the treatment of adult patients with severe COVID-19 A randomized double-blind placebo-included clinical trial
  2. Efficacy and safety of tofacitinib on clinical improvement in hospitalized patients with COVID19: A randomized, double blind multi-centre clinical trial
  3. Evaluation of the effect of Tofacitinib drug (Iranian brand of Rhofanib drug) on clinical and laboratory symptoms in severe and resistant patients with COVID-19
  4. The effects of a diet based on Iranian medicine on clinical outcomes and laboratory biomarkers of patients with COVID-19
  5. The Effect of Inhalation of Thyme Oil with Standard Nationwide Medication on Respiratory Markers and Laboratory Findings in Patients with COVID-19
  6. A single-arm multicenter clinical trial to evaluate the safety and efficacy of Remdesivir in COVID-19 patients with progressive severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  7. Comparison of Effectiveness of Remdesivir with Remdesivir and Interferon Beta-1 a Treatment Regime on Clinical Outcome of Covid 19 Patients
  8. Assessment of utility of Remdesivir in Patients with Acute Kidney Injury or Cronic Kidney Disease in admitted COVID-19 patients
  9. ‏Comparison of the effect of adding nebulized low molecular weight heparin to the treatment of patients with Covid 19 who are treated with Remdesivir on an outpatient basis compared to the usual treatment during five days
  10. : Evaluation of the effect of spironolactone and DDP4 inhibitors on treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
Study aim: Determining the effect of virtual sitting exercises on depression, anxiety and stress in the elderly in the Covid 19 epidemy Design: Random clinical trial with control and test group, community-based and pragmatic, randomized, Excel software rand function is used for randomization. Settings
IRCTID: IRCT20220107053651N1
  1. Investigating the effectiveness of tele-counselling on perinatal mental health during SARS-COV-2 pandemics
  2. Investigating the effectiveness of psychological interventions on mental health of Kerman University of Medical Sciences’s mental health in hospitals and reference clinics
  3. Investigating the impact of breathing exercise ( through virtual education )on the general health of patients infected with Covid-19 in shiraz . Randomized clinical trial
  4. The effect of group teaching technique of attention training technique and detached- mindfulness on the thought action fusion in students with anxiety and stress syndrome
  5. Evaluation of the effectiveness of prenatal self-care training application in Covid 19 pandemic on quality of life, depression, corona anxiety and fear of childbirth in pregnant women
  6. Investigating the effects of mindfulness-based stress reduction (MBSR) in groups and online setting on the severity of pemphigus vulgaris disease and treatment compliance in patients with pemphigus vulgaris
  7. The Effectiveness of Internet-Based Psychological Intervention in patients with symptoms of depression and anxiety
  8. The effect of education on mindfulness-based stress coping skills on psychological distress in patients with Covid 19
  9. Comparing the effectiveness of online Balint group and pharmacotherapy with Selective Serotonin Reuptake Inhibitors in Coronavirus anxiety in healthcare workers.
  10. The effect of supportive role of nurse on stress, anxiety and depression in the hospitalized elderly with COVID-19 in Firoozabadi hospital at Rey city
(exercise less than 1 hour per week), no drug use in the previous 6 months, no person or family has Covid 19
IRCTID: IRCT20140415017288N7
  1. The effect of eight weeks of high intensity interval and continuous training on galectin 3, GDF15, NT-ProBNP and IL6 in overweight men
  2. The effect of 12 weeks of aerobic training on serum levels of galectin3, GDF15 and some inflammatory markers in elderly women with metabolic syndrome
  3. The effect of two training methods High-Intensity Interval Training (HIIT) and Aerobic continuous training (AECT)on serum levels of Meteorin- like hormone, oncostatin M and lipid profile in Overweight and obese women
  4. The effect of aerobic training and spirulina supplementation on resistin and CRP in women with type 2 diabetes
  5. The effect of eight weeks aerobic training with garlic supplements on inflammatory and cardiovascular factors in postmenopausal women with high blood pressure and obesity
  6. Comparison Of The Effect Of Eight Weeks Of Combined Exercise And Curcumin Supplementation On C - Reactive Protein, Ferritin, ESR And Some Functional Factors In Obese Elderly Men
  7. The effect of high intensity interval training with spirulina supplementation on cardiovascular metabolic risk factors and body composition of obese elderly women.
  8. The effect of aerobic training and caffeine consumption on quality of life and life expectancy in overweight men in Gachsaran
  9. The Effect of Aerobic Training on Platelets, Mean Platelet Volume, Prothrombin Time and Thromboplastin Time in Healthy Elderly Men
  10. The effect of spirulina and chitosan supplementation along with eight weeks of combined exercises on blood pressure and lipid profile in hypertensive women.
counseling sessions because of covid 19 pandemic .  Intervention group consuming vitamin D3, met criteria and
IRCTID: IRCT20191231045967N1
; People with a history of Covid -19 after 2 doses of vaccination; People with epilepsy or a history of
IRCTID: IRCT20150303021315N26
  1. A non-randomized, three-armed, non-inferiority, open label, parallel clinical trial to compare the immunogenicity and safety of SpikoGen® vaccine (an adjuvanted recombinant spike (S) protein produced by CinnaGen Co.) in children aged 5-12, adolescents aged 12-18 and adults aged 18-40
  2. A phase II, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days)
  3. A phase III, Randomized, Two-armed, Double-blind, Placebo controlled trial to evaluate efficacy and safety of an adjuvanted recombinant SARS-CoV-2 spike (S) protein subunit vaccine (SpikoGen®) produced by CinnaGen Co. (Two doses of 25µg with dosing interval of 21 days)
  4. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  5. Efficacy, safety, and immunogenicity of Soberana recombinant vaccine (product of Finlay Institute) based on RBD protein subunit of Sars-Cov-2 in a 2-dose regimen with and without a booster dose: a double-blind, randomized, placebo-controlled phase III clinical trial in the Iranian population of 18-80 years
  6. Evaluation of SARS-CoV-۲ Vaccine (Pastocovac) effectiveness and serologic response in Patients Receiving Hematopoietic Autologous Stem Cell Transplantation compared to control group: A clinical trial
  7. Immunogenicity and safety evaluation of Pastocovac Plus as the booster dose in Iranian adults aged from 18 to 80 who received two doses of Sinopharm and Astrazeneca
  8. Comparison of immunogenicity and safety of Razi Cov Pars and Sinopharm booster doses in adults 18 years of age and older who have primarily vaccinated with Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial ‎
  9. Immunogenicity and safety of pastocovac vaccine as a booster dose in comparison with sinopharm and pastocovac Plus boosters in Iranian adults aged 18 to 80 who received 2 doses of Sinopharm vaccine: a parallel group clinical trial
  10. Comparison of safety and immunogenicity of FAKHRAVAC and Sinopharm booster doses for adults 18 years of age and older, fully vaccinated by Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial
angioedema or anaphylactic reactions after receiving previous COVID vaccines (including urticaria and fever
IRCTID: IRCT20201214049709N4
  1. Comparison of safety and immunogenicity of FAKHRAVAC and Sinopharm booster doses for adults 18 years of age and older, fully vaccinated by Sinopharm: a ‎parallel ‎‏2‏‎ arms, ‎randomised, double blind clinical trial
  2. Immunogenicity and Safety of intranasal Razi Cov Pars as a booster dose in adult population; randomised, double blind, placebo controlled clinical trial
  3. Phase II, Safety and Immunogenicity of RAZI SARS-CoV-2 recombinant Spike protein vaccine (RAZI Cov Pars) in adults aged 18-70 years; a Randomised, double blind, parallel 2 arms clinical trial
  4. Phase I, Safety and Immunogenicity of Razi SARS-CoV-2 recombinant Spike protein vaccine (Razi Cov Pars), in healthy adults aged 18-55 years; parallel 4 arms design (adjuvant only and three vaccine doses of 5, 10, and 20 µg/200µl); a Randomised, double blind, clinical trial
  5. Comparison of the safety and efficacy of Razi SARS-CoV-2 recombinant Spike protein (Razi Cov Pars) and Sinopharm vaccines in adults aged 18 and over, a phase III randomised, double blind, non-inferiority clinical trial
  6. A single armed, open label, clinical trial to evaluate the immunogenicity of SpikoGen® vaccine as booster dose (Spike protein, produced by CinnaGen company) in kidney transplant patients being fully vaccinated with Sinopharm vaccine
  7. Safety and Immunogenicity of Razi Cov-2 recombinant Spike protein vaccine (RAZI Cov Pars) in healthy children and adolescents aged 5-17 years; single group, open label study
  8. Immunogenicity and safety evaluation of Pastocovac Plus as the booster dose in Iranian adults aged from 18 to 80 who received two doses of Sinopharm and Astrazeneca
  9. Immunogenicity and safety of pastocovac vaccine as a booster dose in comparison with sinopharm and pastocovac Plus boosters in Iranian adults aged 18 to 80 who received 2 doses of Sinopharm vaccine: a parallel group clinical trial
  10. Phase 2 trial of safety and immunogenicity of 10 micro gram inactivated SARS-CoV-2 vaccine (FAKHRAVAC), two doses two weeks apart in adults aged 18-70 years: a randomized, double-blind, placebo-controlled, clinical trial
the study include: dissatisfaction, Getting Covid-19 and taking vitamin D followed during the study
IRCTID: IRCT20211026052878N1
  1. Efficacy of Mupirocin Ointment into Nostril on polyposis reccurence Following Functional endoscopic sinus surgery (FESS) in Chronic Rhinosinusitis with Nasal Polyposis (CRSwNP)
  2. Assessment of the effect of topical calcitriol on Chronic Rhinosinusitis with and without polyps
  3. Effect of topical vancomycin versus placebo on prevention of sinonasal polyposis recurrence after FESS (Functional Endoscopic Sinus Surgery): A triple blinded randomized clinical trial
  4. Evaluation of the effect of Xylitol nasal spray in treatment of patients with chronic rhinosinusitis
  5. The impact of elemental zinc on patients with chronic sinusitis and polyposis: single-blind randomized controlled trial study
  6. Evaluation of the effect of oral curcumin on reducing the recurrence of nasal polyposis in patients undergoing endoscopic sinus surgery
  7. Comparison of satisfaction and bleeding of Triamcinolone impregnated gelfoam with Triamcinolone impregnated Surgicel in nasal dressing after endoscopic sinus surgery in patients with polyposis
  8. Evaluation of the effect of Tacrolimus drop in preventing the recurrence of nasal polyps in patients with chronic rhinosinusitis after endoscopic sinus surgery
  9. Comparative study of the results of endoscopic sinus surgery and Concurrent Endoscopic Sinus Surgery and rhinoplasty with or without ''Tongue In Groove'' technique in patients undergoing Endoscopic Sinus Surgery
  10. The Effect of Montelukast on Prevention of Nasal Polyps Recurrence Following Functional Endoscopic Sinus Surgery.
greater than 50, lack of sensitivity to amikacin, absence of myasthenia gravis, Absence of covid 19 (PCR
IRCTID: IRCT20220702055337N1
  1. Evaluating the Effectiveness of Nebulized Amikacin and Colistin in Preventing Ventilator-Associated Pneumonia in Intubated Patients Admitted to Intensive Care Units: A Clinical Trial
  2. The effect of the Active And Passive Humidifiers On The Parameters Of Pulmonary And Ventilator Associated Pneumonia In Patients Admitted To Intensive Care Units.
  3. Evaluation of the effectiveness of colistin / rifampin compared to colistin / meropenem in the treatment of ventilator-associated pneumonia (VAP) due to carbapenem-resistant Acinetobacter baumannii: a randomized, controlled clinical trial
  4. Evaluation of the efficacy of colistin / levofloxacin in comparison with colistin / meropenem in the treatment of ventilator-associated pneumonia (VAP) induced by carbapenem-resistant Acinetobacter baumannii: a randomized, controlled clinical trial
  5. The effect of Trachyspermum Ammi syrup on the prevention of ventilator-associated pneumonia in mechanically ventilated patients in the trauma intensive care units
  6. The effect of endotracheal tube cuff pressure (minimum/maximum) in the prevention of ventilator-induced pneumonia in patients admitted to ICU
  7. Comparison of safety and effectiveness of Levofloxacin/Colistin regimen with Levofloxacin/high dose Ampicillin-sulbactam infusion in treatment of Ventilator-Associated Pneumonia due to multi drug resistant Acinetobacter
  8. Comparing the effect of Ranitidin and Pantoprazole on ventilator associated pneumonia (VAP) in trauma patients admitted in ICU of Be'sat hospital
  9. Study of the effect of vitamin D supplementation on outcome and prognostic biomarkers of VAP in patient with vitamin D deficiency
  10. Evaluating the effect of nebulizing colistine with nebulizing colistin-fosfomycin in comparison to nebulizing colistine in Ventillator-Associated Pneumonia with multidrug-resistant Acinetobacter Baumanii in Alzahra Intensive Care Units
-threatening anomalies diagnosed by a doctor ، infants born to mothers with covid-19 ، LGA, IUGR, SGA babies
IRCTID: IRCT20091201002801N5
having the disease of Covid-19 and being sick Intervention groups: Intervention group: The educational
IRCTID: IRCT20221129056661N1
Study aim: The purpose of this research is to investigate the effect of two types of intense interval training (HIIT) and continuous aerobics on the pulmonary and cardiorespiratory functions of wrestlers recovered from corona disease. Design: The clinical trial will include two experimental groups and a control group with a sample size of 45 people, who will be placed in three groups of 15 people by simple random method. Settings and conduct: Subjects will be invited to the sports hall of Islamic Azad University, Kermanshah branch to participate in the orientation session and will be randomly placed in three experimental groups. They will participate in the type of exercise. After the practice period, the post-exam phase was observed by the candidates again, according to the points related to the pre-exam phase. Participants/Inclusion and exclusion criteria: The statistical population includes male wrestlers with an age range of 25-35 years who referred to sports clubs in Kermanshah city in 2022. All participants will be wrestlers who have recovered from corona disease with a history of at least 5 years of sports. None of the subjects will have a history of chronic diseases such as cardiovascular diseases, diabetes, various cancers, kidney and digestive disorders, or any type of injury or problem that prevents them from participating in physical activities. Intervention groups: 45 people will be invited to participate in the briefing session and randomly divided into three experimental groups: experimental group 1 (continuous aerobic exercise of 15 people), experimental group 2 (high-intensity interval training of 15 people) and control group 3 (without exercise 15 people) will be placed. Main outcome variables: Pulmonary and cardio respiratory functions of wrestlers recovered from corona virus infection
IRCTID: IRCT20221213056809N3
  1. The effect of 8 weeks of progressive aerobic exercises with curcumin supplementation on inflammatory indices, lipid indices and cardio-pulmonary function in obese girls recovered from corona
  2. Effect of HIIT and intense resistance training on asprosin and CTRP1 levels in overweight and obese men
  3. The effect of 8 weeks of Whole-Body High-Intensity Interval Training with the consumption of mango leaf extract on the serum levels of NRF2 and antioxidant stress in overweight and obese men
  4. The effect of eight weeks of progressive aerobic activity with consumption of green tea and green coffee on fat oxidation and blood pressure in overweight girls
  5. The effect of eight weeks of high intensity interval training (HIIT), resistance training and consumption of artichoke extract on the level of sirtuin 1 and team enzymes aspartate aminotransferase (AST) and alanine aminotransferase (ALT) in patients with non-alcoholic fatty liver disease
  6. Effects of One Session Moderate-Intensity Aerobic Training and High-Intensity Interval Training on Food Craving- Food Choices- and Some Psychological Factors Related to Appetite Control in Overweight and Obese Women
  7. Investigating the effect of aerobic exercise on immune and inflammatory indicators in patients improved from COVID-19
  8. Comparison of four types of aerobic, resistance, combined (Aerobic - Resistance) and High-intensity interval exercise on coagulation factors (platelets, PT, PTT, and fibrinogen) and fibrinolysis (D-dimer) in healthy untrained young men
  9. The effect of 12 weeks HIIT and MICT training on mitochondrial biogenesis regulatory myokines and glycemic index in type 2 diabetic men
  10. Comparison the effectiveness of a 6 months home-based aerobic High-intensity interval training (HIIT) and resistance exercises on glycemic and metabolic control of adolescents with type 1 diabetes mellitus and identification of disease related microRNAs
Study aim: The purpose of this study is to evaluate eight weeks of progressive aerobic exercises with curcumin supplementation on inflammatory indices, lipid indices and cardio-pulmonary function in obese girls who have recovered from corona after being discharged from the hospital. Design: This research is a semi-experimental method and a clinical trial in the form of a pre-test and a post-test, which will be conducted after ethical approval with an ethics ID from the secretariat of the national ethics committee based in Ilam University and registration in the clinical trial center. The statistical population will include inactive obese girls with an age range of 25-35 years with a body mass index of 35 ± 5 referring to sports clubs in Kermanshah city in 1402. Settings and conduct: With the presence of a nursing expert from the Kermanshah health center, they will be present at the central (reference) laboratory of Kermanshah Participants/Inclusion and exclusion criteria: . None of the subjects had a history of chronic diseases such as cardiovascular diseases, diabetes, various cancers, kidney and digestive disorders, or any type of injury or problem that prevents them from participating in physical activities. Intervention groups: Four experimental groups: experimental group 1 (progressive aerobic exercise + curcumin supplement 10 people), experimental group 2 (progressive aerobic exercise + placebo 10 people), experimental group 3 (curcumin supplement 10 people) and experimental group 4 (control / no intervention 10 people) will be placed. Main outcome variables: Inflammatory indices (IL-6, TNF-a), lipid indices (TG, TC, LDL, HDL) and cardio-respiratory function
IRCTID: IRCT20221213056809N2
  1. The effect of two types of intense interval training (HIIT) and aerobic continuity on pulmonary and cardiorespiratory functions of wrestlers recovered from corona disease
  2. The effect of curcumin supplementation on anthropometric indices, glycemic indices, inflammatory markers, oxidative stress markers and chemerin in healthy overweight/obese female students
  3. The effect of curcumin supplementation with High-intensity interval training on serum Irisin levels and lipid profile in non-active obese women: a randomized clinical trial "
  4. Investigating the effect of aerobic exercise on immune and inflammatory indicators in patients improved from COVID-19
  5. Effect of aerobic and resistance training on body composition, glucose homeostasis, appetite, serum leptin and hs-CRP levels in over weight and obese anxious girls
  6. Effect of aerobic exercise and green tea supplementation on body composition, and cardio metabolic risk factors of overweight and obese women.
  7. The effect of chitosan supplementation on some appetite regulating hormones, intestinal microbiota, anthropometric indices and blood sugar and lipid control indices in overweight and obese adolescents
  8. Effects of cardamom supplementation on antheropometric indices, cardiometabolic status, obesity and diabetes gene expression among obese women with polycystic ovary syndrome
  9. The effect of eight weeks of progressive aerobic activity with consumption of green tea and green coffee on fat oxidation and blood pressure in overweight girls
  10. The effect of curcumin-piperine supplementation on glycemic indices, lipid profiles, anthropometric indices and liver function in children with none- alcoholic fatty liver disease
Loading...